Eliem Therapeutics shares owned by BML Capital Management
Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by BML Capital Management
from 13F filings
Historical chart of BML Capital Management investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by BML Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.0M | 2.2M | 2.74 |
| 2023-12-31 | $5.9M | 2.2M | 2.70 |
| 2023-09-30 | $5.1M | 1.9M | 2.63 |
| 2023-06-30 | $4.4M | 1.6M | 2.80 |
| 2023-03-31 | $4.8M | 1.7M | 2.90 |
| 2022-12-31 | $6.7M | 1.8M | 3.67 |